tm
Seeing Is Believing
tm
Seeing Is Believing
LYEL is currently covered by 3 analysts with an average price target of $35.75. This is a potential upside of $24.71 (223.82%) from yesterday's end of day stock price of $11.04.
Lyell Immunopharma's activity chart (see below) currently has 19 price targets and 37 ratings on display. The stock rating distribution of LYEL is 13.33% HOLD and 86.67% BUY.
Analysts average stock forecasts to be materialized ratio is 29.17% with an average time for these price targets to be met of 42.88 days.
Highest price target for LYEL is $45, Lowest price target is $20, average price target is $35.75.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 11-Sep-2026. First documented stock forecast 12-Jul-2021.
Currently out of the existing stock ratings of LYEL, 2 are a HOLD (13.33%), 13 are a BUY (86.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Apr-2026
$44
$32.96 (298.55%)
$44
1 months 21 days ago
(11-Sep-2026)
0/5 (0%)
$32.04 (267.89%)
Buy Since 09-Mar-2026
$34
$22.96 (207.97%)
$34
4 months ago
(01-Jul-2026)
0/5 (0%)
$21.03 (162.14%)
Buy Since 23-Mar-2026
$45
$33.96 (307.61%)
$45
4 months 23 days ago
(09-Jun-2026)
5/15 (33.33%)
$32.3 (254.33%)
113
Buy Since 26-Sep-2025
$20
$0.33 (1.68%)
1 years 1 months 6 days ago
(26-Sep-2025)
1/1 (100%)
$7.17 (55.88%)
59
Buy Since 12-Jul-2021
$20
$8.96 (81.16%)
2 years 2 days ago
(30-Oct-2024)
1/2 (50%)
$2.84 (16.55%)
2
What is LYEL (Lyell Immunopharma) average time for price targets to be met?
Which analyst most recently updated their price target on LYEL (Lyell Immunopharma)?
Which analyst has the current lower performing score on LYEL (Lyell Immunopharma) with a proven track record?
Which analyst has the most public recommendations on LYEL (Lyell Immunopharma)?
Which analyst is the currently most bullish on LYEL (Lyell Immunopharma)?
Which analyst is the currently most reserved on LYEL (Lyell Immunopharma)?
